Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
50000 participants
OBSERVATIONAL
2018-12-13
2030-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
To participate, you will be asked to:
* Read and sign an online informed consent form
* Take a survey describing specific demographic and type 1 diabetes management information
* Update your information annually
* Periodically opt in for additional research opportunities (if you choose), i.e. taking new surveys or uploading health device data
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Type 1 Diabetes Extension Study
NCT02734277
UK Islet Autoantibody Registry
NCT07125365
Hybrid Closed Loop Effectiveness Trial in Adults With Type 1 Diabetes
NCT06236607
T1D Pregnancy & Me
NCT06959316
Tissue-Specific Metabolic Reprogramming in Diabetic Complications
NCT01823406
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Individuals diagnosed with type 1 diabetes
T1D Exchange Registry is currently looking for participants:
* Of all ages, genders, races, and ethnic groups
* Living in the United States
* Diagnosed with type 1 diabetes
* Currently taking insulin or have had a pancreatic or islet cell transplant
No intervention
Observational research study
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
Observational research study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Individuals younger than 18 years of age must have parent/guardian consent.
* Must be able to read and understand English.
* Currently living in the United States
Exclusion Criteria
* Cannot fully read and understand English.
* Does not currently live in the United States.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
T1D Exchange, United States
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kelsie LaFerriere
Lead Research Study Coordinator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
T1D Exchange
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1822333
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.